Literature DB >> 19375582

Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects.

Kathleen V Fitch1, Lauren M Guggina, Hester M Keough, Sara E Dolan Looby, Colleen Hadigan, Ellen J Anderson, Jane Hubbard, James G Liebau, Stine Johnsen, Jeffery Wei, Hideo Makimura, Takara L Stanley, Janet Lo, Steven K Grinspoon.   

Abstract

The purpose of this study was to evaluate the relationship of respiratory quotient (RQ), a surrogate marker of substrate oxidation, as well as body composition and dietary intake to resting energy expenditure (REE) among HIV-infected patients in the current era of highly active antiretroviral therapy and among non-HIV-infected control subjects. Resting energy expenditure is increased in HIV-infected patients; but little is known regarding the potential contribution of altered substrate metabolism, body composition, and dietary intake to increased energy expenditure in this population. Respiratory quotient, REE, body composition, and dietary intake parameters were assessed in 283 HIV-infected patients and 146 community-derived HIV-negative controls who were evaluated for metabolic studies between 1998 and 2005. Respiratory quotient was lower (0.83 +/- 0.00 vs 0.85 +/- 0.01, P = .005), whereas REE adjusted for fat-free mass (FFM) was higher (31.8 +/- 0.3 vs 29.8 +/- 0.3 kcal/[d kg], P < or = .0001), in HIV-infected compared with control subjects. In multivariate modeling among HIV-infected patients, including age, sex, and parameters of immune function, FFM (beta = 24.811334, P < .0001), visceral adiposity (beta = .7182746, P = .008), and total body fat (beta = 8.0506839, P = .041) were positively associated with REE, whereas RQ was negatively associated with REE (beta = -528.4808, P = .024). Overall r(2) was equal to 0.705 and P was less than .0001 for the model. In control subjects, by contrast, only visceral adiposity (beta = 1.0612073, P = .004), total body fat (beta = 15.805547, P = .010), and FFM (beta = 22.613005, P < .0001) were significant predictors of REE; and there was no relationship with RQ. Overall r(2) was equal to 0.825 and P was less than .0001 for the model. These data suggest that alterations in substrate metabolism may contribute to increased REE in HIV-infected patients compared with control subjects.

Entities:  

Mesh:

Year:  2009        PMID: 19375582      PMCID: PMC2691476          DOI: 10.1016/j.metabol.2008.12.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  40 in total

1.  Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.

Authors:  Amy Fleischman; Stine Johnsen; David M Systrom; Mirko Hrovat; Christian T Farrar; Walter Frontera; Kathleen Fitch; Bijoy J Thomas; Martin Torriani; Hélène C F Côté; Steven K Grinspoon
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-02-06       Impact factor: 4.310

2.  Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.

Authors:  P Rietschel; C Hadigan; C Corcoran; T Stanley; G Neubauer; J Gertner; S Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Fat and carbohydrate balances during adaptation to a high-fat.

Authors:  S R Smith; L de Jonge; J J Zachwieja; H Roy; T Nguyen; J C Rood; M M Windhauser; G A Bray
Journal:  Am J Clin Nutr       Date:  2000-02       Impact factor: 7.045

4.  Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

Authors:  C Hadigan; C Corcoran; N Basgoz; B Davis; P Sax; S Grinspoon
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

5.  Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.

Authors:  Gary Meininger; Colleen Hadigan; Michael Laposata; Joanne Brown; Jessica Rabe; Joseph Louca; Negar Aliabadi; Steven Grinspoon
Journal:  Metabolism       Date:  2002-02       Impact factor: 8.694

6.  Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.

Authors:  L A Kosmiski; D R Kuritzkes; K A Lichtenstein; D H Glueck; P J Gourley; E R Stamm; A L Scherzinger; R H Eckel
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

Review 7.  Dysregulated energy expenditure in HIV-infected patients: a mechanistic review.

Authors:  Evelyn Chang; Rajagopal Sekhar; Sanjeet Patel; Ashok Balasubramanyam
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

8.  Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities.

Authors:  Tisha Joy; Hester M Keogh; Colleen Hadigan; Sara E Dolan; Kathleen Fitch; James Liebau; Stine Johnsen; Janet Lo; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

Review 9.  Indirect calorimetry: a practical guide for clinicians.

Authors:  Heather A Haugen; Lingtak-Neander Chan; Fanny Li
Journal:  Nutr Clin Pract       Date:  2007-08       Impact factor: 3.080

10.  Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era.

Authors:  Tisha Joy; Hester M Keogh; Colleen Hadigan; Hang Lee; Sara E Dolan; Kathleen Fitch; James Liebau; Janet Lo; Stine Johnsen; Jane Hubbard; Ellen J Anderson; Steven Grinspoon
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

View more
  4 in total

1.  Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy.

Authors:  Marcelo A Mori; Thomas Thomou; Jeremie Boucher; Kevin Y Lee; Susanna Lallukka; Jason K Kim; Martin Torriani; Hannele Yki-Järvinen; Steven K Grinspoon; Aaron M Cypess; C Ronald Kahn
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

2.  Accelerating aging research: how can we measure the rate of biologic aging?

Authors:  Joseph B Margolick; Luigi Ferrucci
Journal:  Exp Gerontol       Date:  2015-02-12       Impact factor: 4.032

Review 3.  Energy expenditure in HIV infection.

Authors:  Lisa Kosmiski
Journal:  Am J Clin Nutr       Date:  2011-11-16       Impact factor: 7.045

4.  Aged interleukin-10tm1Cgn chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipokines.

Authors:  Reyhan M Westbrook; Huan Le Yang; Jackie M Langdon; Cindy N Roy; Jin A Kim; Parichoy P Choudhury; Qian-Li Xue; Andrea di Francesco; Rafa de Cabo; Jeremy Walston
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.